Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2012

Open Access 01-12-2012 | Study protocol

RETRACTED ARTICLE: WELL.ME - Wellbeing therapy based on real-time personalized mobile architecture, vs. cognitive therapy, to reduce psychological distress and promote healthy lifestyle in cardiovascular disease patients: study protocol for a randomized controlled trial

Authors: Angelo Compare, Vassilis Kouloulias, Vontas Apostolos, Wendy Moreno Peña, Enrico Molinari, Enzo Grossi, Efstathopoulos Efstathios, Michele Carenini

Published in: Trials | Issue 1/2012

Login to get access

Abstract

Background

There is compelling evidence that psychological factors may have the same or even greater impact on the possibility of adverse events on cardiac diseases (CD) than other traditional clinical risk factors. Anxiety and depression are predictors of short- and long-term adverse outcomes, increased risk for higher rates of in-hospital complications, re-infarction, malignant arrhythmias, and mortality in CD patients. Despite researchers finding that cognitive behavior therapy (CBT) reduced depressive and anxiety symptoms, the fact that such results are maintained only in the short term and the lack of maintenance of the long-term affects the absence of changes in lifestyles, preventing the possibility of a wide generalization of results. Recently wellbeing therapy (WBT) has been proposed as a useful approach to improve healthy lifestyle behaviors and reduce psychological distress.

Methods/design

The present randomized controlled study will test WBT, in comparison with CBT, as far as the reduction of symptoms of depression, anxiety and psychological distress, and the improvement of lifestyle behaviors and quality of life in cardiac patients are concerned. Moreover, innovations in communication technologies allow patients to be constantly followed in real life. Therefore WBT based on personalized mobile technology will allow the testing of its effectiveness in comparison with usual WBT.

Discussion

The present study is a large outpatient study on the treatment of co-morbid depression, anxiety, and psychological distress in cardiac patients. The most important issues of this study are its randomized design, the focus on promotion of health-related behaviors, and the use of innovative technologies supporting patients’ wellbeing in real life and in a continuous way. First results are expected in 2012.

Trial registration

ClinicalTrials.gov Identifier: NCT01543815.
Appendix
Available only for authorised users
Literature
1.
Kubzansky LD, Kawachi I: Going to the heart of the matter: do negative emotions cause coronary heart disease?. J Psychosom Res. 2000, 48: 323-337. 10.1016/S0022-3999(99)00091-4.CrossRefPubMed
2.
Rozanski A, Blumenthal JA, Kaplan J: Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation. 1999, 99: 2192-2217. 10.1161/01.CIR.99.16.2192.CrossRefPubMed
3.
Molinari E, Compare A, Parati G: Clinical psychology and heart disease. 2006, New York: SpringerCrossRef
4.
Compare A, Germani E, Proietti R, Janeway D: Clinical psychology and cardiovascular disease: an up-to-date clinical practice review for assessment and treatment of anxiety and depression. Clin Pract Epidemiol Mental Health. 2011, 7: 148-156. 10.2174/1745017901107010148.CrossRef
5.
Barefoot JC, Helms MJ, Mark DB, Blumenthal JA, Califf RM, Haney TL, O’Connor CM, Siegler IC, Williams RB: Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol. 1996, 78: 613-617. 10.1016/S0002-9149(96)00380-3.CrossRefPubMed
6.
Jiang W, Alexander J, Christopher E, Kuchibhatla M, Gaulden LH, Cuffe MS, Blazing MA, Davenport C, Califf RM, Krishnan RR, O’Connor CM: Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med. 2001, 161: 1849-1856. 10.1001/archinte.161.15.1849.CrossRefPubMed
7.
Zuidersma M, Thombs BD, de Jonge P: Onset and recurrence of depression as predictors of cardiovascular prognosis in depressed acute coronary syndrome patients: asystematic review. Psychother Psychosom. 2011, 80: 227-237. 10.1159/000322633.CrossRefPubMed
8.
Janszky I, Ahnve S, Lundberg I, Hemmingsson T: Early-onset depression, anxiety, and risk of subsequent coronary heart disease: 37-year follow-up of 49,321 young Swedish men. J Am Coll Cardiol. 2010, 56: 31-37. 10.1016/j.jacc.2010.03.033.CrossRefPubMed
9.
Whang W, Shimbo D, Kronish IM, Duvall WL, Julien H, Iyer P, Burg MM, Davidson KW: Depressive symptoms and all-cause mortality in unstable angina pectoris (from the Coronary Psychosocial Evaluation Studies [COPES]). Am J Cardiol. 2010, 106: 1104-1107. 10.1016/j.amjcard.2010.06.015.CrossRefPubMedPubMedCentral
10.
Nabi H, Shipley MJ, Vahtera J, Hall M, Korkeila J, Marmot MG, Kivimaki M, Singh-Manoux A: Effects of depressive symptoms and coronary heart disease and their interactive associations on mortality in middle-aged adults: the Whitehall II cohort study. Heart. 2010, 96: 1645-1650. 10.1136/hrt.2010.198507.CrossRefPubMed
11.
Watkins LL, Blumenthal JA, Babyak MA, Davidson JR, McCants CB, O’Connor C, Sketch MH: Phobic anxiety and increased risk of mortality in coronary heart disease. Psychosom Med. 2010, 72: 664-671. 10.1097/PSY.0b013e3181e9f357.CrossRefPubMedPubMedCentral
12.
Haworth JE, Moniz-Cook E, Clark AL, Wang M, Waddington R, Cleland JG: Prevalence and predictors of anxiety and depression in a sample of chronic heart failure patients with left ventricular systolic dysfunction. Eur J Heart Fail. 2005, 7: 803-808. 10.1016/j.ejheart.2005.03.001.CrossRefPubMed
13.
Jiang W, Kuchibhatla M, Cuffe MS, Christopher EJ, Alexander JD, Clary GL, Blazing MA, Gaulden LH, Califf RM, Krishnan RR, O’Connor CM: Prognostic value of anxiety and depression in patients with chronic heart failure. Circulation. 2004, 110: 3452-3456. 10.1161/01.CIR.0000148138.25157.F9.CrossRefPubMed
14.
Falk K, Patel H, Swedberg K, Ekman I: Fatigue in patients with chronic heart failure - a burden associated with emotional and symptom distress. Eur J Cardiovasc Nurse. 2009, 8: 91-96. 10.1016/j.ejcnurse.2008.07.002.CrossRef
15.
Scherer M, Himmel W, Stanske B, Scherer F, Koschack J, Kochen MM, Herrmann-Lingen C: Psychological distress in primary care patients with heart failure: a longitudinal study. Br J Gen Pract. 2007, 57: 801-807.PubMedPubMedCentral
16.
Tsuchihashi-Makaya M, Kato N, Chishaki A, Takeshita A, Tsutsui H: Anxiety and poor social support are independently associated with adverse outcomes in patients with mild heart failure. Circ J. 2009, 73: 280-287. 10.1253/circj.CJ-08-0625.CrossRefPubMed
17.
Friedmann E, Thomas SA, Liu F, Morton PG, Chapa D, Gottlieb SS: Relationship of depression, anxiety, and social isolation to chronic heart failure outpatient mortality. Am Heart J. 2006, 152: 940-e1-8CrossRefPubMed
18.
Kubzansky LD, Kawachi I, Weiss ST, Sparrow D: Anxiety and coronary heart disease: a synthesis of epidemiological, psychological, and experimental evidence. Ann Behav Med. 1998, 20: 47-58. 10.1007/BF02884448.CrossRefPubMed
19.
Moser DK, Dracup K: Is anxiety early after myocardial infarction associated with subsequent ischemic and arrhythmic events?. Psychosom Med. 1996, 58: 395-401.CrossRefPubMed
20.
Manzoni GM, Villa V, Compare A, Castelnuovo G, Nibbio F, Titon AM, Molinari E, Gondoni LA: Short-term effects of a multi-disciplinary cardiac rehabilitation programme on psychological well-being, exercise capacity and weight in a sample of obese in-patients with coronary heart disease: a practice-level study. Psychol Health Med. 2011, 16: 178-189. 10.1080/13548506.2010.542167.CrossRefPubMed
21.
Lesperance F, Frasure-Smith N, Koszycki D, Laliberte MA, van Zyl LT, Baker B, Swenson JR, Ghatavi K, Abramson BL, Dorian P, Guertin MC, CREATE Investigators: Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA. 2007, 297: 367-379. 10.1001/jama.297.4.367.CrossRefPubMed
22.
Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ, Czajkowski SM, DeBusk R, Hosking J, Jaffe A, Kaufmann PG, Mitchell P, Norman J, Powell LH, Raczynski JM, Schneiderman N, Enhancing Recovering in Coronary Heart Disease Patients Investigators (ENRICHD): Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery In Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA. 2003, 289: 3106-3116.CrossRefPubMed
23.
Barlow DH, Gorman JM, Shear MK, Woods SW: Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. JAMA. 2000, 283: 2529-2536. 10.1001/jama.283.19.2529.CrossRefPubMed
24.
Gary RA, Dunbar SB, Higgins MK, Musselman DL, Smith AL: Combined exercise and cognitive behavioral therapy improves outcomes in patients with heart failure. J Psychosom Res. 2010, 69: 119-131. 10.1016/j.jpsychores.2010.01.013.CrossRefPubMedPubMedCentral
25.
Ryff CD: In the eye of the beholder: views of psychological well-being among middle-aged and older adults. Psychological Aging. 1989, 4: 195-201.CrossRef
26.
Ruini C, Fava GA: Well-being therapy for generalized anxiety disorder. J Clin Psychol. 2009, 65: 510-519. 10.1002/jclp.20592.CrossRefPubMed
27.
Fava GA, Ruini C, Rafanelli C, Finos L, Salmaso L, Mangelli L, Sirigatti S: Well-being therapy of generalized anxiety disorder. Psychother Psychosom. 2005, 74: 26-30. 10.1159/000082023.CrossRefPubMed
28.
Fava GA, Ruini C: Development and characteristics of a well-being enhancing psychotherapeutic strategy: well-being therapy. J Behav Ther Exp Psychiatry. 2003, 34: 45-63. 10.1016/S0005-7916(03)00019-3.CrossRefPubMed
29.
Fava GA, Rafanelli C, Tomba E, Guidi J, Grandi S: The sequential combination of cognitive behavioral treatment and well-being therapy in cyclothymic disorder. Psychother Psychosom. 2011, 80: 136-143. 10.1159/000321575.CrossRefPubMed
30.
Beck AT, Rush AJ, Shaw BF, Emery G: Cognitive therapy of depression. 1979, New York, NY: Guilford Press
31.
Spitzer RL, Kroenke K, Williams JB: Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999, 282: 1737-1744. 10.1001/jama.282.18.1737.CrossRefPubMed
32.
Lamers F, Jonkers CC, Bosma H, Penninx BW, Knottnerus JA, van Eijk JT: Summed score of the Patient Health Questionnaire-9 was a reliable and valid method for depression screening in chronically ill elderly patients. J Clin Epidemiol. 2008, 61: 679-687. 10.1016/j.jclinepi.2007.07.018.CrossRefPubMed
33.
Lowe B, Decker O, Muller S, Brahler E, Schellberg D, Herzog W, Herzberg PY: Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Medical Care. 2008, 46: 266-274. 10.1097/MLR.0b013e318160d093.CrossRefPubMed
34.
Fava GA, Freyberger HJ, Bech P, Christodoulou G, Sensky T, Theorell T, Wise TN: Diagnostic criteria for use in psychosomatic research. Psychother Psychosom. 1995, 63: 1-8. 10.1159/000288931.CrossRefPubMed
35.
36.
Ware J, Kosinski M, Keller SD: A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Medical Care. 1996, 34: 220-233. 10.1097/00005650-199603000-00003.CrossRefPubMed
37.
Demoly P, Gueron B, Annunziata K, Adamek L, Walters RD: Update on asthma control in five European countries: results of a 2008 survey. Eur Respir Rev. 2010, 19: 150-157. 10.1183/09059180.00002110.CrossRefPubMed
38.
Dupuy HJ: The Psychological General Well-being (PGWB) Index. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. Edited by: Wenger NK, Mattson ME, Furburg CD, Elinson J. 1990, New York, NY: Le Jacq Publishing, 170-183.
39.
Grossi E, Groth N, Mosconi P, Cerutti R, Pace F, Compare A, Apolone G: Development and validation of the short version of the Psychological General Well-Being Index (PGWB-S). Health Qual Life Outcomes. 2006, 4: 88-10.1186/1477-7525-4-88.CrossRefPubMedPubMedCentral
40.
Omvik P, Thaulow E, Herlan O, Eide I, Midha R, Turner R: Double-blind, parallel, comparative study on quality of life during treatment with amlodipine or enalapril in mild or moderate hypertensive patients: a multicenter study. J Hypertens. 1993, 11: 103-113. 10.1097/00004872-199301000-00015.CrossRefPubMed
41.
Rector TS, Cohn JN: Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. Am Heart J. 1992, 124: 1017-1025. 10.1016/0002-8703(92)90986-6.CrossRefPubMed
42.
Cohen J: Statistical power analysis for the behavioural sciences. 1988, Hillsdale, NJ: Erlbaum, 2
Metadata
Title
RETRACTED ARTICLE: WELL.ME - Wellbeing therapy based on real-time personalized mobile architecture, vs. cognitive therapy, to reduce psychological distress and promote healthy lifestyle in cardiovascular disease patients: study protocol for a randomized controlled trial
Authors
Angelo Compare
Vassilis Kouloulias
Vontas Apostolos
Wendy Moreno Peña
Enrico Molinari
Enzo Grossi
Efstathopoulos Efstathios
Michele Carenini
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Trials / Issue 1/2012
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/1745-6215-13-157

Other articles of this Issue 1/2012

Trials 1/2012 Go to the issue

Study protocol

Study protocol of a mixed-methods evaluation of a cluster randomized trial to improve the safety of NSAID and antiplatelet prescribing: data-driven quality improvement in primary care

Research

Removing barriers to participation in clinical trials, a conceptual framework and retrospective chart review study

Review

Factors contributing to therapeutic effects evaluated in acupuncture clinical trials

Methodology

The value of the pragmatic-explanatory continuum indicator summary wheel in an ongoing study: the bullous pemphigoid steroids and tetracyclines study

Research

The Patient Deficit Model Overturned: a qualitative study of patients' perceptions of invitation to participate in a randomized controlled trial comparing selective bladder preservation against surgery in muscle invasive bladder cancer (SPARE, CRUK/07/011)

Study protocol

Effect of low-level laser therapy on pain, quality of life and sleep in patients with fibromyalgia: study protocol for a double-blinded randomized controlled trial